394 related articles for article (PubMed ID: 10813729)
1. Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary.
Bruening W; Giasson BI; Klein-Szanto AJ; Lee VM; Trojanowski JQ; Godwin AK
Cancer; 2000 May; 88(9):2154-63. PubMed ID: 10813729
[TBL] [Abstract][Full Text] [Related]
2. Expression of alpha-, beta- and gamma-synuclein in colorectal cancer, and potential clinical significance in progression of the disease.
Ye Q; Wang TF; Peng YF; Xie J; Feng B; Qiu MY; Li LH; Lu AG; Liu BY; Zheng MH
Oncol Rep; 2010 Feb; 23(2):429-36. PubMed ID: 20043104
[TBL] [Abstract][Full Text] [Related]
3. Expression of alpha-, beta-, and gamma-synuclein in glial tumors and medulloblastomas.
Fung KM; Rorke LB; Giasson B; Lee VM; Trojanowski JQ
Acta Neuropathol; 2003 Aug; 106(2):167-75. PubMed ID: 12783249
[TBL] [Abstract][Full Text] [Related]
4. The expression of alpha-, beta-, and gamma-synucleins in olfactory mucosa from patients with and without neurodegenerative diseases.
Duda JE; Shah U; Arnold SE; Lee VM; Trojanowski JQ
Exp Neurol; 1999 Dec; 160(2):515-22. PubMed ID: 10619569
[TBL] [Abstract][Full Text] [Related]
5. Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomies.
Roland IH; Yang WL; Yang DH; Daly MB; Ozols RF; Hamilton TC; Lynch HT; Godwin AK; Xu XX
Cancer; 2003 Dec; 98(12):2607-23. PubMed ID: 14669280
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of synuclein-gamma in pancreatic adenocarcinoma.
Li Z; Sclabas GM; Peng B; Hess KR; Abbruzzese JL; Evans DB; Chiao PJ
Cancer; 2004 Jul; 101(1):58-65. PubMed ID: 15221989
[TBL] [Abstract][Full Text] [Related]
7. Stage-specific expression of breast cancer-specific gene gamma-synuclein.
Wu K; Weng Z; Tao Q; Lin G; Wu X; Qian H; Zhang Y; Ding X; Jiang Y; Shi YE
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):920-5. PubMed ID: 14504205
[TBL] [Abstract][Full Text] [Related]
8. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
[TBL] [Abstract][Full Text] [Related]
9. Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas.
Dong Y; Kaushal A; Bui L; Chu S; Fuller PJ; Nicklin J; Samaratunga H; Clements JA
Clin Cancer Res; 2001 Aug; 7(8):2363-71. PubMed ID: 11489814
[TBL] [Abstract][Full Text] [Related]
10. Alpha-synuclein immunoreactivity in normal and neoplastic Schwann cells.
Mori F; Inenaga C; Yoshimoto M; Umezu H; Tanaka R; Takahashi H; Wakabayashi K
Acta Neuropathol; 2002 Feb; 103(2):145-51. PubMed ID: 11810180
[TBL] [Abstract][Full Text] [Related]
11. The role of CpG islands hypomethylation and abnormal expression of neuronal protein synuclein-gamma (SNCG) in ovarian cancer.
Czekierdowski A; Czekierdowska S; Wielgos M; Smolen A; Kaminski P; Kotarski J
Neuro Endocrinol Lett; 2006 Jun; 27(3):381-6. PubMed ID: 16816827
[TBL] [Abstract][Full Text] [Related]
12. Disabled-2 inactivation is an early step in ovarian tumorigenicity.
Fazili Z; Sun W; Mittelstaedt S; Cohen C; Xu XX
Oncogene; 1999 May; 18(20):3104-13. PubMed ID: 10340382
[TBL] [Abstract][Full Text] [Related]
13. Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosis.
Wu K; Quan Z; Weng Z; Li F; Zhang Y; Yao X; Chen Y; Budman D; Goldberg ID; Shi YE
Breast Cancer Res Treat; 2007 Mar; 101(3):259-67. PubMed ID: 16821081
[TBL] [Abstract][Full Text] [Related]
14. Gamma synuclein: subcellular localization in neuronal and non-neuronal cells and effect on signal transduction.
Surguchov A; Palazzo RE; Surgucheva I
Cell Motil Cytoskeleton; 2001 Aug; 49(4):218-28. PubMed ID: 11746666
[TBL] [Abstract][Full Text] [Related]
15. [Expression of alpha-tubulin and gamma-tubulin in premalignant lesion and carcinoma of breast and the significance thereof].
Niu Y; Wang Y; Yu Y; Ding XM; Lü SH; Xiao XQ
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(1):56-60. PubMed ID: 16606540
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic oophorectomy: a morphologic and immunohistochemical study.
Schlosshauer PW; Cohen CJ; Penault-Llorca F; Miranda CR; Bignon YJ; Dauplat J; Deligdisch L
Cancer; 2003 Dec; 98(12):2599-606. PubMed ID: 14669279
[TBL] [Abstract][Full Text] [Related]
17. p16 overexpression: a potential early indicator of transformation in ovarian carcinoma.
Shigemasa K; Hu C; West CM; Clarke J; Parham GP; Parmley TH; Korourian S; Baker VV; O'Brien TJ
J Soc Gynecol Investig; 1997; 4(2):95-102. PubMed ID: 9101469
[TBL] [Abstract][Full Text] [Related]
18. The expression of Fhit protein is related inversely to disease progression in patients with breast carcinoma.
Gatalica Z; Lele SM; Rampy BA; Norris BA
Cancer; 2000 Mar; 88(6):1378-83. PubMed ID: 10717620
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of centrosomal alpha, gamma-tubulin in atypical ductal hyperplasia and carcinoma of the breast.
Niu Y; Liu T; Tse GM; Sun B; Niu R; Li HM; Wang H; Yang Y; Ye X; Wang Y; Yu Q; Zhang F
Cancer Sci; 2009 Apr; 100(4):580-7. PubMed ID: 19215229
[TBL] [Abstract][Full Text] [Related]
20. Genomic organization and expression of the human beta-synuclein gene (SNCB).
Lavedan C; Leroy E; Torres R; Dehejia A; Dutra A; Buchholtz S; Nussbaum RL; Polymeropoulos MH
Genomics; 1998 Nov; 54(1):173-5. PubMed ID: 9806846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]